The transcription factor NF-B regulates genes involved in inflammatory and immune responses, tumorigenesis, and apoptosis. In contrast to the pleiotropic stimuli that lead to its positive regulation, the known signaling mechanisms that underlie the negative regulation of NF-B are very few. Recent studies have identified the tumor suppressor CYLD, loss of which causes a benign human syndrome called cylindromatosis, as a key negative regulator for NF-B signaling by deubiquitinating tumor necrosis factor (TNF) receptor-associated factor (TRAF) 2, TRAF6, and NEMO (NF-B essential modulator, also known as I B kinase ␥). However, how CYLD is regulated remains unknown. The present study revealed a novel autoregulatory feedback pathway through which activation of NF-B by TNF-␣ and bacterium nontypeable Haemophilus influenzae (NTHi) induces CYLD that in turn leads to the negative regulation of NF-B signaling. In addition, TRAF2 and TRAF6 appear to be differentially involved in NF-B-dependent induction of CYLD by TNF-␣ and NTHi. These findings provide novel insights into the autoregulation of NF-B activation.The transcription factor NF-B plays critical roles in regulating inflammatory and immune responses, tumorigenesis, and protection against apoptosis (1-3). Previous studies identified an inducible feedback inhibition pathway for controlling I B␣ gene transcription and down-regulation of transient activation of NF-B (4 -6). Recent studies have identified the tumor suppressor CYLD 1 as a key negative regulator for NF-B signaling by deubiquitinating tumor necrosis factor (TNF) receptor-associated factor (TRAF) 2, TRAF6, and NEMO (7-9). However, how CYLD is regulated is totally unknown. It is still unclear whether activation of NF-B induces CYLD transcription that in turn leads to the inhibition of NF-B especially in more delayed or persistent phase in an autoregulatory feedback manner.To determine whether CYLD is induced during inflammation, we first sought to evaluate the effects on CYLD expression of a variety of inflammation stimuli such as proinflammatory cytokines and bacteria. Having demonstrated that CYLD is indeed induced by TNF-␣, interleukin-1 (IL-1) and nontypeable Haemophilus influenzae (NTHi), an important Gramnegative bacterial pathogen for respiratory infections, we next sought to determine whether activation of NF-B is required for CYLD induction based on the fact that all of the above CYLD inducers are also potent inducers for NF-B.Here we showed that activation of NF-B is indeed required for CYLD induction by TNF-␣, IL-1, and NTHi and that TRAF2 and TRAF6 are differentially involved in NF-B-dependent induction of CYLD by TNF-␣ and NTHi. The present study thus revealed a novel autoregulatory feedback pathway through which activation of NF-B by TNF-␣ and NTHi induces CYLD that in turn leads to the inhibition of NF-B signaling. These findings should enhance our understanding of the negative feedback regulation of NF-B activation during inflammation.
MATERIALS AND METHODSReagents-MG-132 was purchased from ...